Unified-planning, graded-administration, and centralized-controlling: a management modality for treating acquired immune deficiency syndrome with Chinese medicine in Henan Province of China

Li-ran Xu; Hui-jun Guo; Zhi-bin Liu; Qiang Li; Ji-ping Yang; Ying He

doi:10.1007/s11655-015-2138-x

Your Location：

Home >

Browse articles >

Unified-planning, graded-administration, and centralized-controlling: a management modality for treating acquired immune deficiency syndrome with Chinese medicine in Henan Province of China

Updated：2021-08-27

- Unified-planning, graded-administration, and centralized-controlling: a management modality for treating acquired immune deficiency syndrome with Chinese medicine in Henan Province of China
- Chinese Journal of Integrative Medicine Vol. 21, Issue 4, Pages: 243-248(2015)
- Affiliations：
  
  1. Department of Acquired Immune Deficiency Syndrome Treatment and Research Center, the First Affiliated Hospital of Henan University of Traditional Chinese Medicine,Zhengzhou,China
  2. Cellular Immunology Lab, Key Laboratory of Viral Diseases Prevention and Treatment of Traditional Chinese Medicine of Henan Province,Zhengzhou,China
  3. Discinpline of Internal Chinese Medicine, the First Affiliated Hospital of Henan University of Traditional Chinese Medicine,Zhengzhou,China
  4. Department of Dermatology, the First Affiliated Hospital of Henan University of Traditional Chinese Medicine,Zhengzhou,China
- Author bio：
- Funds：
  
  Supported by the National Special Science and Technology Program on Major Infectious Diseases (No. 2013ZX10005001-001, No. 2012ZX10005001-005), Henan Province Colleges and Universities Key Youth Teachers Scheme (No. 2013GGJS-095), and Plan For Scientific Innovation Talent of Henan Province (No. 2015-025)
- DOI：10.1007/s11655-015-2138-x
  CLC：
- Published：2015，
  
  Published Online：16 April 2015，
Scan for full text
Xu, Lr., Guo, Hj., Liu, Zb. et al. Unified-planning, graded-administration, and centralized-controlling: a management modality for treating acquired immune deficiency syndrome with Chinese medicine in Henan Province of China., Chin. J. Integr. Med. 21, 243–248 (2015). https://doi.org/10.1007/s11655-015-2138-x

Li-ran Xu, Hui-jun Guo, Zhi-bin Liu, et al. Unified-planning, graded-administration, and centralized-controlling: a management modality for treating acquired immune deficiency syndrome with Chinese medicine in Henan Province of China. [J]. Chinese Journal of Integrative Medicine 21(4):243-248(2015)
Xu, Lr., Guo, Hj., Liu, Zb. et al. Unified-planning, graded-administration, and centralized-controlling: a management modality for treating acquired immune deficiency syndrome with Chinese medicine in Henan Province of China., Chin. J. Integr. Med. 21, 243–248 (2015). https://doi.org/10.1007/s11655-015-2138-x DOI：

Li-ran Xu, Hui-jun Guo, Zhi-bin Liu, et al. Unified-planning, graded-administration, and centralized-controlling: a management modality for treating acquired immune deficiency syndrome with Chinese medicine in Henan Province of China. [J]. Chinese Journal of Integrative Medicine 21(4):243-248(2015) DOI： 10.1007/s11655-015-2138-x.

摘要

Henan Province in China has a major epidemic of human immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS). Chinese medicine (CM) has been used throughout the last decade

and a management modality was developed

which can be described by unified-planning

graded-administration

and centralized-controlling (UGC). The UGC modality has one primary concept (patient-centered medicine from CM theory)

four basic foundations (classifying administrative region

characteristics of CM on disease treatment

health resource conditions

and distribution of patients living with HIV)

six important relationships (the “three uniformities and three combinations

” and the six relationships therein guide the treatment of AIDS with CM)

and four key sections (management

operation

records

and evaluation). In this article

the authors introduce the UGC modality

which could be beneficial to developing countries or resource-limited areas for the management of chronic infectious disease.

Abstract

Henan Province in China has a major epidemic of human immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS). Chinese medicine (CM) has been used throughout the last decade

and a management modality was developed

which can be described by unified-planning

graded-administration

and centralized-controlling (UGC). The UGC modality has one primary concept (patient-centered medicine from CM theory)

four basic foundations (classifying administrative region

characteristics of CM on disease treatment

health resource conditions

and distribution of patients living with HIV)

six important relationships (the “three uniformities and three combinations

” and the six relationships therein guide the treatment of AIDS with CM)

and four key sections (management

operation

records

and evaluation). In this article

the authors introduce the UGC modality

which could be beneficial to developing countries or resource-limited areas for the management of chronic infectious disease.

关键词

acquired immune deficiency syndromeChinese Medicinecomplementary and alternative medicineantiretroviral therapy

Keywords

acquired immune deficiency syndromeChinese Medicinecomplementary and alternative medicineantiretroviral therapy

references

Sepkowitz KA. AIDS—the first 20 years. N Engl J Med 2001;344:1764–1772.

UNAIDS. UNAIDS report on the global AIDS epidemic. In; 2013. 4.

Wu Z, Liu Z, Detels R. HIV-1 infection in commercial plasma donors in China. Lancet 1995;346:61–62.

Zhuang K, Gui X, Su B, Tien P, Chen Z, Zhang L. High prevalence of HIV infection among women and their children in Henan Province, China. J Acquir Immun Defic Syndr 2003;33:649–650.

Liu ZB, Wang X, Liu HJ, Jin YT, Guo HJ, Jiang ZQ, et al. Treatment of acquired immunodeficiency syndrome with Chinese medicine in China: opportunity, advancement and challenges. Chin J Integr Med 2013;19:563–567.

Zhang MM, Liu XM, He L. Effect of integrated traditional Chinese and Western medicine on SARS: a review of clinical evidence. World J Gastroenterol 2004;10:3500–3505.

Wang C, Cao B, Liu QQ, Zou ZQ, Liang ZA, Gu L, et al. Oseltamivir compared with the Chinese traditional therapy Maxingshigan-Yinqiaosan in the treatment of H1N1 influenza: a randomized trial. Ann Intern Med 2011;155:217–225.

Tu JW, Dong MJ, Liu ZY, Li Y, Chen J. A control study on Chinese medicine for light of common type of epidemic encephalitis B. J Tradit Chin Med (Chin) 2013;54:1028–1030.

Deng X, Liang J, Wu FS, Li YB, Tang YF. Effects of the Ganning formula on liver fibrosis in patients. J Tradit Chin Med 2011;31:282–287.

Xu LR, Li FZ, He Y, Guo JZ, Wang D. Sixty month clinical observation of HIV carriers/AIDS patients treated with Yiaikang capsule in terms of theirs CD+4 T counts and viral loads. Chin J AIDS STD (Chin) 2010;16:231–233.

Wang BL, Liu XM, Guo BT, Yang XJ, Liu ZB, Jiang ZQ. The effect of Yiaikang Capsules on immune function of HIV/AIDS patients. J Henan Univ Chin Med (Chin) 2008;23:138–140.

Li FZ, Xu LR, Zhang ML, Guo JZ. Clinical observation on 885 AIDS patients treated by Yiaikang Capsule combined with treatment based on syndrome differentiation. J Tradit Chin Med (Chin) 2010;51:808–810.

Xie SP, Guo HJ, Xu QL, Guo YM, Pan WQ. Effect of Aikang Capsule on life quality in HIV/AIDS patients. Shanghai J Tradit Chin Med (Chin) 2007;41:15–18.

Huang L, Zhou CJ, Liang FL, Lu XE, Wang ZM. Treatment of HAART associated hepatic function damage with Danggui Shaoyao Powder in 48 AIDS patients. Tradit Chin Med Res (Chin) 2007;20:55–56.

Jin YT, Liu ZB, Chen XM, Wang X, Wang D, Ji ZQ, et al. Survival of people living with HIV after treatment with traditional Chinese medicine in Henan province of China: a retrospective cohort study. J Tradit Chin Med 2014;34:430–436.

Li Q, Xu QL, Guo HJ. Some thoughts on present clinical research of HIV/AIDS. World Sci Technol Modern Tradit Chin Med Mater Med (Chin) 2013;15:901–904.

Liu ZB, Yang JP, Liu HJ, Jin YT. Factors associated with fatigue in acquired immunodeficiency syndrome patients with antiretroviral drug adverse reactions: a retrospective study. J Tradit Chin Med 2013;33:316–321.

Liu ZB, Xie Z, Li Z, Jin YT, Guo HJ, Jiang ZQ, et al. Reliability and validity of dermatology life quality index: assessment of quality of life in human immunodeficiency virus/acquired immunodeficiency syndrome patients with pruritic popular eruption. J Tradit Chin Med 2013;33:580–583.

Liu ZB, Jin YT, Yang JP, Lei Q, Xu LR, Li Q, et al. Prevalence and related factors of anemia among human immunodeficiency virus (HIV)/acquired immune deficiency syndrome (AIDS) outpatients in resources limited region of China. 2013 IEEE International Conference on Bioinformatics and Biomedicine 2013;157–160.

FULL TEXT LINK

More>

Views

Downloads

CSCD

Alert me when the article has been cited

Submit

Tools

Publicity Resources

Cancer complementary and alternative medicine research at the US national cancer institute

Disease-syndrome combination clinical study of psoriasis: Present status, advantages, and prospects

Effects and mechanisms of actions of Chinese herbal medicines for asthma

Chinese medicine for menopausal syndrome: Current status, problems and strategies

Traditional Chinese medicine for modern treatment of Parkinson’s disease

Related Author

No data

Related Institution

Office of Cancer Complementary and Alternative Medicine, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda

Guangdong Provincial Hospital of Traditional Chinese medicine

Second Clinical College, Guangzhou University of Chinese medicine

Center for Chinese Medicine for Allergy and Asthma, Jaffe Food Allergy Institute, Pediatric Department, Division of Allergy and Immunology, The Mount Sinai School of Medicine

Respiratory Department, Zhangzhou Traditional Chinese Medicine Hospital, Affiliated Hospital of Fujian University of Traditional Chinese Medicine

Address：1 Caochang, xiyuan, Beijing, People's Republic of China Postal code：100091
Tel：010-62886827, 62877592 Fax：010-62874291
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备05067934号-1 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰